市場調查報告書
商品編碼
1008066

感染管理的全球市場預測(2020年∼2026年)

Infection Control Market 2020-2026

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球感染管理的市場規模,預計在預測期間內以約在預測期間內以約6.8%的年複合成長率擴大。感染管理,主要是防止在在醫院和診療所的醫療保健部門的感染擴大。促進感染管理市場成長的主要原因中,包含慢性疾病的發生率上升和外科手術增加。再加上外科手術增加,政府為了促進全球有效率的預防措施相關的意識指南增加,及院內感染(HAI)的高發生率也促進著市場成長。

無菌製造商對產品批准的嚴格限制可能會抑制這個市場的成長。可是,殺菌技術的進步和電子束殺菌的使用增加,帶給這個市場新的機會。

本報告提供全球感染管理市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 法規和規則

第3章 競爭情形

  • 企業佔有率分析
  • 主要的策略分析
  • 主要企業分析
    • Getinge AB
    • STERIS Corp.
    • Ecolab Inc.
    • Belimed AG
    • 3M Co.

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 各設備市場
    • 消毒劑
    • 殺菌設備
  • 各終端用戶市場
    • 醫院及診療所
    • 製藥公司
    • 醫療設備廠商
    • 其他
  • 各類服務市場
    • ETO殺菌服務
    • 伽馬射線殺菌服務
    • 電子束殺菌服務
    • 其他

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Advanced Sterilization Products Services Inc.
  • Alimed Inc.
  • Cardinal Health, Inc.
  • Cisa Production S.r.l. Unipersonale
  • Coloplast A/S
  • Evonik Industries AG
  • Matachana Group
  • Metrex Research, LLC
  • MMM Group
  • Owens & Minor
  • Pal International Ltd.
  • Reckitt Benckiser Group PLC
  • Sotera Health Co.
  • Steelco S.p.A.
  • Terragene SA
目錄
Product Code: OMR2023359

Global Infection Control Market Size, Share & Trends Analysis Report by Equipment (Disinfectors and Sterilization Equipment), By End-User (Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, and Others), By Services (ETO Sterilization Services, Gamma Sterilization Services, E-Beam Sterilization Services, and Others), and Forecast Period 2021-2027

The global infection control market is anticipated to grow at a CAGR of nearly 6.8% during the forecast period. Infection control prevents the spread of infections in the healthcare sector, primarily in hospitals and clinics. Infection control supports in reducing the occurrence of infectious diseases which are usually caused by bacteria or viruses present in the environment. The key factors that are motivating the growth of the infection control market include the rising incidences of chronic diseases and the rising number of surgical procedures. In addition, the increasing number of surgical procedures, the rising issue of guidelines by the government to promote awareness about efficient prevention measures globally, and the high incidence of hospital-acquired infections (HAIs) are also driving the growth of the market. For instance, in March 2020, the World Health Organization (WHO) has issued guidelines for the prevention and control of COVID-19 pandemic and respiratory diseases in healthcare. The guidelines issued for the precautions such as hand hygiene, usage of personal protective equipment, to guidelines for disinfection, and sterilization.

Furthermore, the increasing demand for sterilization method in pharmaceutical companies, and the technological advancement in sterilization equipment are the factors that are propelling the growth of the market. Stringent regulation for sterilization manufacturer in terms of product approval may restrict the growth of this market. Besides, rising concerns regarding the safety and performance of reprocessed devices are also hindering the market growth. However, advances in sterilization technology and increasing use of E-beam sterilization have brought new opportunity for this market.

Segmental Outlook

The global infection control market is segmented based on equipment, end-user, and services. Based on the equipment, the market is segmented into disinfectors and sterilization equipment. Based on the end-user, the market is segmented into hospitals and clinics, pharmaceutical companies, medical device companies, and others. Based on the services, the market is segmented into ETO sterilization services, gamma sterilization services, e-beam sterilization services, and others.

Global Infection Control Market Share by End-User, 2020 (%)

Source: OMR Global

Hospitals and Clinics holds Significant share in the Market During the Forecast Period

In 2020, hospitals and clinics held the largest share in the market owing to the rising prevalence of the HAIs and emerging focus on cleaning and disinfection solutions across hospitals and clinics to prevent the spread of the infection. In American hospitals alone, the Centers for Disease Control (CDC) estimates that healthcare-acquired infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths annually. In addition, the rising number of surgeries performed in hospitals and the rising number of multi-specialty hospitals is also contributing to the potential share of infection control techniques in hospitals.

Regional Outlook

The market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America region represents considerably the largest market for infection control in terms of revenue generation. It is growing due to strict regulation on infection prevention in hospitals and the significant prevalence of healthcare-acquired infections (HAIs) in the region. In addition, the presence of major players such as Ecolab Inc, STERIS Corp., and others are further contributing to the launch of new infection control products in the region. Along with this, Germany has a significant share in the Europe infection control market owing to the rising number of surgeries performed in the country and significant growth in the medical device industry in the country.

Global Infection Control Market Growth, by Region 2021-2027

Source: OMR Global

Asia-Pacific is expected to have considerable shares in the global Infection Control market

Asia-Pacific is anticipated to hold considerable market share in the market owing to the presence of pharmaceutical outsourcing organizations, rising healthcare expenditure, and well-developed healthcare standards and infrastructure. Increasing pharmaceutical and medical device industries, increasing incidence of nosocomial infections, and improving healthcare infrastructure in the region are the important factors that are driving the infection control market in the Asia-pacific region. In addition, the COVID-19 pandemic has further encouraged the adoption of infection prevention and control products across healthcare infrastructure.

Market Players Outlook

Key players operating in the market include 3M Co., ASP Global manufacturing GmbH, Belimed AG, Ecolab, Inc., Getinge AB, and Steris Corp. The market players are focusing on various strategic initiatives such as mergers & acquisitions, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Getinge declared the acquisition of Quadralene, a manufacturer of, and expert in, decontamination products including detergents and disinfectants for the healthcare and dental sector. Quadralene will be a part of Infection Control in the business area of Surgical Workflows of Getinge.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global infection control market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules and Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Getinge AB
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. STERIS Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Ecolab Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Belimed AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. 3M Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Infection Control Market byEquipment
    • 5.1.1. Disinfectors
    • 5.1.2. Sterilization Equipment
      • 5.1.2.1. Radiation Sterilization
      • 5.1.2.2. Heat Sterilization
      • 5.1.2.3. Low Temperature Sterilization
      • 5.1.2.4. Others
  • 5.2. Global Infection Control Market by End-User
    • 5.2.1. Hospitals and Clinics
    • 5.2.2. Pharmaceutical Companies
    • 5.2.3. Medical Device Companies
    • 5.2.4. Others
  • 5.3. Global Infection Control Market by Services
    • 5.3.1. ETO Sterilization Services
    • 5.3.2. Gamma Sterilization Services
    • 5.3.3. E-Beam Sterilization Services
    • 5.3.4. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Advanced Sterilization Products Services Inc.
  • 7.2. Alimed Inc.
  • 7.3. Cardinal Health, Inc.
  • 7.4. Cisa Production S.r.l. Unipersonale
  • 7.5. Coloplast A/S
  • 7.6. Evonik Industries AG
  • 7.7. Matachana Group
  • 7.8. Metrex Research, LLC
  • 7.9. MMM Group
  • 7.10. Owens & Minor
  • 7.11. Pal International Ltd.
  • 7.12. Reckitt Benckiser Group PLC
  • 7.13. Sotera Health Co.
  • 7.14. Steelco S.p.A.
  • 7.15. Terragene SA

LIST OF TABLES

  • 1. GLOBAL INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY EQUIPMENT,2020-2027 ($ MILLION)
  • 2. GLOBAL DISINFECTORSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL STERILIZATION EQUIPMENTMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 5. GLOBAL INFECTION CONTROL IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL INFECTION CONTROL IN PHARMACEUTICAL COMPANIESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL INFECTION CONTROL IN MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL INFECTION CONTROL IN OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL INFECTION CONTROLMARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
  • 10. GLOBAL ETO STERILIZATION SERVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL GAMMA STERILIZATION SERVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBALE-BEAM STERILIZATION SERVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL OTHER INFECTION CONTROL SERVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL STEAM STERILIZATION SERVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL INFECTION CONTROLMARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY EQUIPMENT,2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
  • 20. EUROPEAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. EUROPEAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY EQUIPMENT,2020-2027 ($ MILLION)
  • 22. EUROPEAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
  • 23. EUROPEAN INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY EQUIPMENT,2020-2027 ($ MILLION)
  • 26. ASIA-PACIFIC INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
  • 27. ASIA-PACIFIC INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)
  • 28. REST OF THE WORLD INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY EQUIPMENT,2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY END USER, 2020-2027 ($ MILLION)
  • 31. REST OF THE WORLD INFECTION CONTROL MARKET RESEARCH AND ANALYSIS BY SERVICES, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INFECTION CONTROL MARKET SHARE BY EQUIPMENT,2020 VS 2027 (%)
  • 2. GLOBAL INFECTION CONTROL MARKET SHARE BY END USER, 2020 VS 2027 (%)
  • 3. GLOBAL INFECTION CONTROL MARKET SHARE BY SERVICES, 2020 VS 2027 (%)
  • 4. GLOBAL INFECTION CONTROL MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL DISINFECTORSMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL STERILIZATION EQUIPMENTMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL INFECTION CONTROL IN HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL INFECTION CONTROL IN PHARMACEUTICAL COMPANIESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBALINFECTION CONTROL IN MEDICAL DEVICE COMPANIES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL INFECTION CONTROL IN OTHER END-USERS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL ETO STERILIZATION SERVICESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL GAMMA STERILIZATION SERVICESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL E-BEAM STERILIZATION SERVICESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL OTHER INFECTION CONTROL SERVICESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. US INFECTION CONTROL MARKET SIZE, 2020-2027($ MILLION)
  • 16. CANADA INFECTION CONTROL MARKET SIZE, 2020-2027($ MILLION)
  • 17. UK INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. FRANCE INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. GERMANY INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. ITALY INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. SPAIN INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF EUROPE INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. INDIA INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CHINA INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. JAPAN INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SOUTH KOREA INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF THE WORLD INFECTION CONTROL MARKET SIZE, 2020-2027 ($ MILLION)